Cite Filings / SABS / 0001493152-25-016846

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

SAB Biotherapeutics, Inc. Filed 2025-10-03 Acc 0001493152-25-016846

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-14 SCHEDULE 13G Statement of Beneficial Ownership
2025-10-03 SCHEDULE 13G Statement of Beneficial Ownership
2025-10-03 SCHEDULE 13D Beneficial Ownership Report
2025-10-03 SCHEDULE 13G Statement of Beneficial Ownership
2025-10-01 4 Director acquired 1,740,000 shares (option exercise)
2025-10-01 4 Director acquired 1,740,000 shares (option exercise)
2025-09-30 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…